Nearly four out of five hospitalized children receive medications that have been tested and approved only for adults, according to a study of hundreds of thousands of patient records. This so-called “off-label” use of drugs was thought to be especially common in children, and the new research, the largest-ever U.S. pediatric study, confirms this.
Forms of ill treatment during captivity that do not involve physical pain — such as psychological manipulation, deprivation, humiliation and forced stress positions — appear to cause as much mental distress and traumatic stress as physical torture, according to a report in the March issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Kraft Canada Inc. is warning the public not to consume certain packages of Christie Chewy Chunks Ahoy! cookies. This product may have been subject to tampering with a small sharp metal object.
At this week’s major HIV/AIDS research meeting, Pfizer presented pivotal data of its experimental medicine, maraviroc, which tackles HIV in an entirely new way. A 24 week analysis showed that approximately twice as many patients receiving maraviroc with an optimized background regimen achieved undetectable virus in the blood than if an optimized regimen was given alone.
The Indian Government is setting up a National Institute of Food Technology Entrepreneurship & Management at Kundli in Haryana.
Results from two ongoing Phase III studies of ISENTRESS? (raltegravir), an investigational oral integrase inhibitor, demonstrated significantly greater antiretroviral activity of ISENTRESS when used in combination with optimized background therapy (OBT) versus placebo plus OBT in treatment-experienced HIV-infected patients who had failed antiretroviral therapies (ARTs), and who had HIV virus resistant to at least one drug in each of the three available classes of oral ARTs.
The U.S. Food and Drug Administration (FDA) issued final guidance that describes FDA?s current approach to communicating drug safety information, including emerging safety information, to the public.
Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding the safety and efficacy of over-the-counter pediatric cough and cold medicines:
Cancer Research UK has said that the “jury is still out” on the health benefits of vitamin supplements following research saying that some may be associated with reduced lifespan.
The Hong Kong Centre for Health Protection (CHP) of the Department of Health is following up 14 members of a tour group who developed symptoms of acute gastroenteritis after traveling to Egypt from February 16 to 25.